Yi Fan

Bristol-Myers Squibb (United States)

Papers

1

Total Citations

5

H-Index

1

About

Dr. Yi Fan has made significant contributions to oncology drug discovery, with a primary focus on developing high-throughput and automated methodologies for cancer research. Their most cited work, "Establishing a High-Throughput and Automated Cancer Cell Proliferation Panel for Oncology Lead Optimization" (2013, 5 citations), introduced a pioneering approach that leverages robotic systems to maintain cell culture and perform cell proliferation assays. This innovation has substantially enhanced the efficiency and reproducibility of tumor cell proliferation testing, which is critical for target validation, lead compound identification, and optimization, as well as assessing compound off-target activities. Dr. Fan's work has streamlined the drug development pipeline, enabling faster and more accurate evaluation of potential oncology therapeutics. By integrating automation into cell-based assays, they have addressed key challenges in lead optimization, reducing manual variability and increasing throughput. Though early in their career, Dr. Fan's contributions represent an important step toward modernizing preclinical oncology research, demonstrating how technological integration can accelerate the discovery of effective cancer treatments. Their work continues to influence researchers seeking to improve drug discovery workflows.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Establishing a High-Throughput and Automated Cancer Cell Proliferation Panel for Oncology Lead Optimization
5 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Bristol-Myers Squibb (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago